Sachdev, Jasgit C., Jessica N. Snider, Jeffrey W. Allen, Lee S. Schwartzberg, Robyn R. Young, Ahmed Y. Javed, Matthew P. Smeltzer, Furhan Yunus, Carmel S. Verrier, and Mohammad Jahanzeb. 1. “NEOADJUVANT WEEKLY NAB-PACLITAXEL PLUS CARBOPLATIN FOLLOWED BY DOXORUBICIN PLUS CYCLOPHOSPHAMIDE WITH BEVACIZUMAB ADDED CONCURRENTLY TO CHEMOTHERAPY FOR OPERABLE TRIPLE-NEGATIVE INVASIVE BREAST CANCER”. Journal of Cancer & Allied Specialties 2 (1). https://doi.org/10.37029/jcas.v2i1.59.